EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

MediciNova Announces Full Enrollment in ALS Biomarker Clinical Trial

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), t...
Continue Reading →
Europe

Direct-to-Patient Clinical Trials

Dates: August 09-10, 2018 Location: Philadelphia, PA Positive patient experiences lead to successful clinical trials with high adherence and high participation rates....
Continue Reading →
Europe

Clinical Trials for CAR T Cells at Bezos Family Immunotherapy Clinic

https://youtu.be/tBH6Y3MQvFs David G. Maloney, MD, PhD, medical director of immunotherapy at the Seattle Cancer Care Alliance and member of Fred Hutchinson Research C...
Continue Reading →
Europe

NIH-funded researchers present preliminary clinical trial results suggesting aggressive blood pressure control may lower risk of cognitive impairment

What Preliminary findings from a large clinical trial, the Systolic Blood Pressure Intervention Trial (SPRINT) Memory and Cognition IN Decreased Hypertension (SPRINT ...
Continue Reading →
Europe

NIH delays controversial clinical trials policy for some studies

Some basic studies, such as a project at the University of Minnesota in Minneapolis studying teenagers’ behavior, are n...
Continue Reading →
Asia Pacific

Korea’s ViroMed acquires DNA-producing facility for clinical trial in U.S.

ViroMed, a Korean developer of biologic drugs, Wednesday announced it has acquired a DNA production facility in San Diego, California, adding a manufacturing function...
Continue Reading →
Europe

PROSTATE CANCER DRUG BYPRODUCT CAN FUEL CANCER CELLS, UNITED STATES-BASED RESEARCHERS FIND

A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research in the United Sta...
Continue Reading →
Europe

Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease

ANAVEX®2-73 Being Studied as Potential First Precision Medicine Biomarker-guided, Targeted Therapeutic in Alzheimer’s Disease Primary and Secondary Endpoints mea...
Continue Reading →
Australasia

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases

Prana enrols and doses its first cohort of healthy volunteers in its Phase I clinical trial Evidence supports activity of PBT434 to prevent α-synuclein accumulat...
Continue Reading →
Europe

Medicare should ‘pay it forward’ on clinical trials

“Innovation,” particularly in health, is a policy buzzword these days. Former House Speaker, Newt Gingrich, penned an opinion piece over the weekend that called on Re...
Continue Reading →
Quotient